| Execution period | 60 months |
|---|
NSE filing, NSE: NAVINFLUOR. Summary written from the filing by ALFA Finder's alert engine.
Navin Fluorine International Ltd: key numbers
- Share price
- ₹8,785.00
- Market cap
- ₹45,095 Cr
- Revenue (annual)
- ₹3,314 Cr
- Net profit (annual)
- ₹663.5 Cr
- P/E (TTM)
- 49.5×Sector 33.9×
- Promoter holding
- 27.08%+0.00% QoQ
- FII holding
- 23.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Navin Fluorine International Ltd
All →Navin Fluorine International Earnings Call Transcript: Key Takeaways
Navin Fluorine delivered a massive 57% revenue growth driven by strong HPP and Specialty segments. Management maintained a robust 34.2% EBITDA margin despite a volatile geopolitical environment.
- Call
- Guides 25% growth
Navin Fluorine International Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 1,190.7 Cr (+57% YoY), EBITDA Rs 407.5 Cr (+66%), margin 34.2%, PAT Rs 269.2 Cr (+81%). Growth across all three verticals.
Navin Fluorine International Dividend
Navin Fluorine declared ₹8 per share interim dividend for FY 27. Record date is November 5, 2026; payment on or after November 26, 2026.
Navin Fluorine International Q2 FY27 Results: Net Profit ₹269.2 Cr, Up 81.4% YoY
Navin Fluorine International Ltd reported revenue from operations of ₹1,191 Cr (+57.0% YoY) and net profit of ₹269.2 Cr (+81.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹269.2 Cr · +81.4% YoY
Navin Fluorine International Order Update: ₹1,710 Cr
Navin Fluorine's subsidiary NFASL amended its $410M Honeywell/Solstice HFO contract, extending tenure to December 2032. Additional revenue potential is about $180M, taking total contract value to about $590M.
- Value
- ₹1,710 Cr
- From
- Solstice Advanced Materials US, Inc. (assignee of Honeywell International Inc.)
- Execution
- Extended to December 2032 (total 11 years)
Navin Fluorine International Employee Stock Options
Navin Fluorine allotted 23,500 equity shares to employees on exercise of options under its ESOP Scheme 2017. No cash consideration or transaction value is stated in the filing.
Other management change announcements
All →Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krowniq Management Change
Krowniq Limited appointed Mr. Mahesh Sharma as Company Secretary and Compliance Officer, effective 04-11-2026, following a board meeting on the same day. The filing is a Key Managerial Personnel change disclosure.
One Global Service Provider Management Change
One Global Service Provider appointed Padmakar Pandit as Non-Executive Independent Director for 60 months. Sanjay Upadhyay was re-appointed Executive Director, effective April 22, 2027.
Whirlpool of India Management Change
Whirlpool of India disclosed the resignations of Head-Accounting Prafulla Kandpal and Head-Taxation Vijay Waghmore. Their relieving dates are 30 October and 13 November 2026.
PDS Management Change
PDS Limited disclosed the resignation of Non-Executive Independent Director Bangalore Gangaiah Srinivas, effective November 4, 2026. The resignation cites pre-occupation and personal commitments, with no other material reason.
Arvee Laboratories (India) Management Change
Arvee Laboratories appointed Shalin Chokshi as Executive Director and Duttsagar Chavda as Company Secretary, both effective 3 November 2026. Non-executive director Saurin Gandhi resigned from the Board effective the same date.